Company intelligence / Profile preview

Ichor Life Sciences

LaFayette/Syracuse, New York, United Statesichorlifesciences.com ↗

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Ichor Life Sciences provides full-service preclinical to clinical trial support as a contract research organization with expertise in drug discovery for longevity and age-related diseases. It has enabled the launch of multiple biotech startups focused on novel therapeutics but does not publicly disclose results from proprietary clinical programs.

Therapeutic areas: OtherOncologyOphthalmology
Modalities: Small moleculeProteinBiologic (including protein expression and cell-based assays)
Industry: Biotech

Drug pipeline

1 asset

Lysoclear

Preclinical

Partnerships

Works with major pharmaceutical clients as a CRO and leads investments/incubation of biotech startups such as Lento Bio and Cypris Therapeutics

Beyond the preview

Go deeper on Ichor Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ichor Life Sciences.